Effects of glycopirronium inhalation therapy evaluated by change of physical activity for untreated chronic obstructive pulmonary disease (COPD) patients.
Phase 2
Recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Registration Number
- JPRN-UMIN000014303
- Lead Sponsor
- Department of Respiratory Medicine, Osaka Police Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy 2. Closed angle glaucoma 3. Severe urination disorder 4. A history of hypersensitivity reaction against glycopirronium 5. A recent history of respiratory infection and acute exacerbation in the previous one month. 6. Clinically severe athma. 7. Other significant cardiac diseases or medical problems precluding ambulatory activity at hom 8. Physician's decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of activity intensity of 1 or more, accessed by accelerometer.
- Secondary Outcome Measures
Name Time Method 1. Pulmonary functions; FVC, FEV1,FEV1%, V50, V25 2. QOL and activity ; CAT, SF-36, modified MRC 3. Physical activity; calorie consumption, steps, amount of exercise 4. Arterial blood test; PaO2, PaCO2 5. Exacerbation episode